SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Net Current Assets History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹11 Cr | ₹3.50 Cr | ₹9.03 Cr | ₹7.47 Cr | ₹7.08 Cr |
What is the latest Net Current Assets ratio of SHUKRA PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹11 Cr |
Mar2022 | ₹3.50 Cr |
Mar2021 | ₹9.03 Cr |
Mar2020 | ₹7.47 Cr |
Mar2019 | ₹7.08 Cr |
How is Net Current Assets of SHUKRA PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹11 Cr | 202.32 | |
Mar2022 | ₹3.50 Cr | -61.27 | |
Mar2021 | ₹9.03 Cr | 20.88 | |
Mar2020 | ₹7.47 Cr | 5.51 | |
Mar2019 | ₹7.08 Cr | - |
Compare Net Current Assets of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹487.5 Cr | -7.8% | 23.9% | 531.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | -7.8% |
23.9% |
531.6% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses